Pharmacoeconomics: Open Access

Department of Clinical Correlates, London South Bank University, Borough Rd, UK, London South Bank University, UK

Publications

• Opinion   
  Systematic Review of Utility Values Used in the Pharmacoeconomic Evaluations for Schizophrenia: Implications on Cost-effectiveness Results
  Author(s): Elena Debreu*
  
  The use of utility values in pharmacoeconomic evaluations plays a crucial role in determining the cost-effectiveness of treatments, particularly in chronic and debilitating conditions like schizophrenia. Utility values represent the preferences for different health states, often quantified on a scale where 0 represents death and 1 represents perfect health. These values are essential in calculating quality-adjusted life years, a key measure used in cost-utility analyses to assess the value of medical interventions. In the context of schizophrenia, a condition characterized by profound impacts on mental health, functioning, and quality of life, utility values are central to understanding the trade-offs between treatment costs and patient outcomes [1]. This systematic review examines the utility values used in pharmacoeconomic evaluations for schizophrenia, highlighting their implicatio.. Read More»
  DOI: 10.37421/2472-1042.2024.9.258

  Abstract HTML PDF